Skip to main content
AUTOBIO DIAGNOSTICS CO., LTD logo

AUTOBIO DIAGNOSTICS CO., LTD — Investor Relations & Filings

Ticker · 603658 ISIN · CNE100002GC4 LEI · 300300HTZSCUCA32U369 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 1,290 across all filing types
Latest filing 2021-06-03 Regulatory Filings
Country CN China
Listing Shanghai Stock Exchange 603658

About AUTOBIO DIAGNOSTICS CO., LTD

https://en.autobio.com.cn/

Autobio Diagnostics Co., Ltd. specializes in the research, development, manufacturing, and distribution of comprehensive in vitro diagnostic (IVD) solutions. The company offers an extensive portfolio of products across multiple clinical disciplines, including immunoassay, microbiology, and molecular diagnostics. Key offerings include high-throughput chemiluminescence immunoassay (CLIA) systems, enzyme-linked immunosorbent assay (ELISA) kits, and automated microbiology platforms for blood culture and microbial identification. Autobio also provides integrated laboratory automation systems designed to enhance diagnostic efficiency and accuracy. By focusing on technological innovation and quality, the company serves clinical laboratories, hospitals, and medical institutions worldwide, supporting the detection of infectious diseases, oncology markers, and various metabolic disorders.

Recent filings

Filing Released Lang Actions
安图生物关于二级子公司取得医疗器械生产许可证的公告
Regulatory Filings Classification · 95% confidence The document is a short announcement regarding a subsidiary obtaining a medical device production license. It includes company and license details but does not contain financial data, management changes, or regulatory filings related to financial performance. It is an official company announcement about a business operational license acquisition, which does not fit into categories like Annual Report, Earnings Release, or Management Reports. It is not a report publication announcement since it does not mention any report release. The best fitting category is Regulatory Filings (RNS) as a general regulatory announcement that does not fit other specific categories.
2021-06-03 Chinese
安图生物关于参加河南辖区上市公司2021年投资者网上集体接待日活动的公告
Regulatory Filings Classification · 95% confidence The document is a short announcement (515 characters) about the company's participation in an investor online collective reception day event. It mentions the date, time, and participants but does not contain any financial data, report content, or detailed presentation materials. It is not a report itself but an announcement of an event for investor interaction. The document does not fit into categories like Annual Report, Earnings Release, or Investor Presentation. Given its nature as a public notice about an investor event, it best fits under Regulatory Filings (RNS) as a general regulatory announcement that does not fit other specific categories.
2021-06-01 Chinese
安图生物关于全资子公司完成医疗器械生产许可证变更登记的公告
Regulatory Filings Classification · 95% confidence The document is a company announcement regarding the change in the medical device production license of a wholly-owned subsidiary. It details the updated license information, production scope changes, and states the impact on the company. The document is short (730 characters) and is an announcement of a regulatory update rather than a financial report or detailed management information. It does not fit into categories like Annual Report, Interim Report, or Earnings Release. It is a regulatory announcement about a license change, which fits best under Regulatory Filings (RNS) as a general regulatory announcement that does not fit other specific categories.
2021-05-25 Chinese
安图生物2020年年度权益分派实施公告
Notice of Dividend Amount Classification · 95% confidence The document is titled as an announcement regarding the implementation of the 2020 annual equity distribution by Zhengzhou Antu Bioengineering Co., Ltd. It details the dividend per share, share transfer ratios, relevant dates for dividend distribution, and the shareholder meeting approval date. The content focuses on dividend amounts, payment dates, share capital changes due to bonus shares, and tax treatment of dividends. There is no detailed financial statement or comprehensive report content, but rather a formal announcement of dividend distribution and share capital changes following shareholder approval. The document length is 2780 characters, which is relatively short and consistent with an announcement rather than a full report. This fits the definition of a Notice of Dividend Amount (DIV), which announces dividend amounts, payment dates, and related details for shareholders.
2021-05-20 Chinese
安图生物2020年年度股东大会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a detailed announcement of the resolutions passed at the 2020 Annual General Meeting (AGM) of Zhengzhou Antu Bioengineering Co., Ltd. It includes voting results on various agenda items such as the 2020 board work report, financial reports, profit distribution, appointment of auditors, and other corporate matters. The document also confirms the legality and validity of the meeting and resolutions, witnessed by lawyers. The content is focused on the official voting results and decisions made at the AGM, not the full annual report or financial statements themselves. The document length is about 4786 characters, which is consistent with a detailed voting results announcement rather than a full report. Therefore, the document fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA).
2021-05-13 Chinese
安图生物2020年年度股东大会法律意见书
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a legal opinion letter from a law firm regarding the legality and compliance of the 2020 Annual General Meeting (AGM) of Zhengzhou Antu Bioengineering Co., Ltd. It details the convening, attendance, voting procedures, and results of the AGM. The document does not contain financial statements or detailed financial performance data but focuses on the legal validation of the AGM process and voting outcomes. This type of document is typically classified as Declaration of Voting Results & Voting Rights Announcements (DVA) because it reports official results from shareholder votes at the AGM. The document length is 4293 characters, which is consistent with a detailed voting results announcement rather than a full annual report or other filings.
2021-05-13 Chinese

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.